RSV vaccine snapshot (reproduced from the PATH website at

Slides:

Advertisements

Similar presentations

دانشکده سرمایه گذار مبانی و مدل

Advertisements

Antiviral Review 22 November :45 PM.

Ebolavirus Vaccines: Progress in the Fight Against Ebola Virus Disease

Centers for Disease Control/Food and Drug Administration algorithm for second-generation HIV tests (20). †, an immunofluorescence assay (IFA) for HIV-1.

Call : Website: -

FMDV-specific IgG, IgG1, and IgG2 in sera of guinea pigs (n = 6/group) immunized on days 1 and 21 by intramuscular injection of FMDV antigens (type O)

Virus-specific serum antibody response of BALB/c mice to DNA prime followed by VRP boost. Virus-specific serum antibody response of BALB/c mice to DNA.

Protection from influenza virus challenge.

FMD VP1-specific IgG, IgG1, and IgG2 in sera of guinea pigs (n = 6/group) immunized on days 1 and 21 by intramuscular injection of FMDV antigens (type.

Detection of CSFV-specific antibodies in immunized/challenged pigs using blocking ELISA. Groups of pigs (n = 5) were inoculated with different doses of.

Virus-specific serum antibody response of BALB/c mice to DNA prime followed by VRP boost. Virus-specific serum antibody response of BALB/c mice to DNA.

Development and Laboratory Evaluation of a Real-Time PCR Assay for Detecting Viruses and Bacteria of Relevance for Community-Acquired Pneumonia Alicia.

Immune response to vaccination with AVA in healthy human subjects (human immunogenicity study). Immune response to vaccination with AVA in healthy human.

Relationship between prechallenge AVA-induced TNA levels and probability of animal survival following lethal challenge with B. anthracis spores in rabbit.

Assessment of CD40L expression and function for diagnosis of X-linked hyper-IgM syndrome (XL-HIGM). Assessment of CD40L expression and function for diagnosis.

Serum neutralizing antibody response of BALB/c mice to DNA prime followed by VRP boost. Serum neutralizing antibody response of BALB/c mice to DNA prime.

DOCK8 protein expression in lymphocytes from a healthy individual.

Epidemiology of viral respiratory infections in a tertiary care centre in the era of molecular diagnosis, Geneva, Switzerland, 2011–2012 J. Ambrosioni,

Antibody endpoint titers induced by PfCelTOS vaccines containing various adjuvant formulations with emulsion doses of 0.5% to 2% (vol/vol) oil, as measured.

Longevity of mucosal and systemic antibody responses induced by pulmonary vaccination. Longevity of mucosal and systemic antibody responses induced by.

Kathleen M Neuzil, Karen L Kotloff The Lancet Global Health

Determination of IL-5+ and IL-6+ cells in the lamina propria of the small intestines of mice receiving L. casei administration. Determination of IL-5+

Increased proinflammatory cytokine production is dependent on both the training interval and the resting time. Increased proinflammatory cytokine production.

Contribution of individual serovars within serogroups isolated in the United States in Contribution of individual serovars within serogroups isolated.

Pulmonary vaccination induces a long-term immune memory response to antigen challenge. Pulmonary vaccination induces a long-term immune memory response.

Anti-inflammatory cytokine production is increased in trained monocytes. Anti-inflammatory cytokine production is increased in trained monocytes. (A) IL-10.

ROS production is a component of trained immunity for some stimuli.

Reproducibility of LPA results for cryopreserved PBMC after variable periods of storage in liquid nitrogen. Reproducibility of LPA results for cryopreserved.

Viability and viable cell recovery of cryopreserved PBMC after variable periods of storage in liquid nitrogen. Viability and viable cell recovery of cryopreserved.

Antibody endpoint titers induced by PfCelTOS vaccines containing various adjuvant formulations with emulsion doses of 0.02% to 2% (vol/vol) oil, as measured.

Trained immunity induction of glycolysis.

T. gondii-specific IgG antibodies in 32 pregnant women treated with spiramycin from the time of diagnosis until delivery and in 16 nonpregnant patients.

Antibody titers against surface antigens of B

Trained immunity effects on cell morphology and numbers.

FeLV p27 antigenemia ELISA data.

RTA pepscan analysis of sera from RiVax- and RVEc-immunized mice.

Testing algorithms for syphilis diagnosis.

RTA-specific serum IgG antibody titers and TNA in mice immunized with RiVax or RVEc. RTA-specific serum IgG titers after the second (A) or third (B) immunizations.

NK activity in healthy donors (n=51) and patients with FRH upon recurrence (n=28) and remission (n=23). NK activity in healthy donors (n=51) and patients.

Dilution of anti-C6 monoclonal antibody shows the broader linear range of the Multiplex assay in comparison to standard ELISA. Shown is the dilution of.

Reproducibility of CD4+ and CD8+ T-cell enumeration with cryopreserved PBMC after variable periods of storage in liquid nitrogen. Reproducibility of CD4+

Reproducibility of the enumeration of the percentages of CD4+ CD45RA+ CD95−, CD4+ CD38+, and CD8+ CD38+ in cryopreserved PBMC after variable periods of.

Antibody titers against surface antigens of M

Viral detection and viral evasion.

Relation between the total white blood count and the absolute lymphocyte count prior to the first vaccination and the response to vaccination. Relation.

Identification of the recombinant structural proteins expressed in recombinant baculovirus-infected Sf9 cells by immunofluorescence assay with rabbit anti-FMDV.

DTH responses to multiple components of the ID93 fusion protein.

Individual values for the tTg-IgA Celikey assay (A), the tTG-IgG Celikey assay (B), the DGP (IgA+IgG) screen (C), and the tTG-IgA Immulite 2000 assay (D),

Evidence-based management of bronchiolitis.

Group-averaged IL-10 levels (in pg/ml) from the Luminex assay for control, CFS with FM, and CFS without FM groups. Group-averaged IL-10 levels (in pg/ml)

Long-lived antibody-secreting cells in the bone marrow, induced by PfCelTOS vaccines containing various adjuvant formulations with emulsion doses of 0.02%

Long-lived antibody-secreting cells in the bone marrow, induced by PfCelTOS vaccines containing various adjuvant formulations with emulsion doses of 0.5%

Time to culling for mastitis among J5 vaccinates and controls

Antigen-specific cytokine production detected by multiplex bead assay (Luminex) 3 weeks after the 3rd immunization. Antigen-specific cytokine production.

Representative results of immunofixation electrophoresis (IFE) of cryoglobulins. Representative results of immunofixation electrophoresis (IFE) of cryoglobulins.

Anti-PT IgG results from 227 patients with coughs of unknown etiology who reported the severity of cough on a scale from 0 to 10. Anti-PT IgG results from.

Optimization of incubation time for visibly stained spot formation in Vero-E6 infected by four serotype DENVs and the efficiency of DENV-4 plaque formation.

Furin-dependent infection following ECM attachment.

Lkt antibody titers of vaccinated and control groups of BHS

Determination of CD-206 and TLR-2 receptors in immune cells in lamina propria of the small intestine of mice given L. casei. Determination of CD-206 and.

Schematic presentation of the major domains of Alps, the signal peptide (S), the N-terminal region (N), the repeat region (R), and the C-terminal region.

Time to culling for all reasons among J5 vaccinates and controls

IgA and IgG antibodies reactive to TT, alpha-toxin, and BSA in two groups of chickens 2 weeks after oral gavage with probiotics or with PBS. The two groups.

Distribution of responses to vaccine antigens in the culture-positive individual group and the control group. Distribution of responses to vaccine antigens.

Variability between laboratories in titer estimations (expressed as GCV on the y axis) tends to be higher for samples in low measurement ranges and to.

Determination of S-IgA against L. casei CRL 431 epitopes.

Presentation transcript:

RSV vaccine snapshot (reproduced from the PATH website at http://sites RSV vaccine snapshot (reproduced from the PATH website at http://sites.path.org/vaccinedevelopment/respiratory-syncytial-virus-rsv/ [accessed 19 January 2016]). RSV vaccine snapshot (reproduced from the PATH website at http://sites.path.org/vaccinedevelopment/respiratory-syncytial-virus-rsv/ [accessed 19 January 2016]). BCG, Mycobacterium bovis BCG; mAb, monoclonal antibody; MVA, modified vaccinia Ankara virus; PIV, parainfluenza virus; SeV, Sendai virus; TBD, to be determined; VLP, virus-like particle. Kathleen M. Neuzil Clin. Vaccine Immunol. 2016; doi:10.1128/CVI.00037-16